Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.

Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, Zeng Y, Chang E, Habte F, Sinclair R, Gambhir SS, Massoud TF, Paulmurugan R.

Biomaterials. 2019 Oct;218:119342. doi: 10.1016/j.biomaterials.2019.119342. Epub 2019 Jul 12.

PMID:
31326657
2.

Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.

Di Ianni T, Bose RJC, Sukumar UK, Bachawal S, Wang H, Telichko A, Herickhoff C, Robinson E, Baker S, Vilches-Moure JG, Felt SA, Gambhir SS, Paulmurugan R, Dahl JD.

J Control Release. 2019 Jul 18;309:1-10. doi: 10.1016/j.jconrel.2019.07.024. [Epub ahead of print]

PMID:
31326463
3.

Emergence of multiple fluorophores in individual cesium lead bromide nanocrystals.

Zhang Y, Guo T, Yang H, Bose R, Liu L, Yin J, Han Y, Bakr OM, Mohammed OF, Malko AV.

Nat Commun. 2019 Jul 2;10(1):2930. doi: 10.1038/s41467-019-10870-1.

4.

FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.

Adams EJ, Karthaus WR, Hoover E, Liu D, Gruet A, Zhang Z, Cho H, DiLoreto R, Chhangawala S, Liu Y, Watson PA, Davicioni E, Sboner A, Barbieri CE, Bose R, Leslie CS, Sawyers CL.

Nature. 2019 Jul;571(7765):408-412. doi: 10.1038/s41586-019-1318-9. Epub 2019 Jun 26.

PMID:
31243370
5.

The Democratization of Diagnosis: Bringing the Power of Medical Diagnosis to the Masses.

Bose R, Saxon LA.

EClinicalMedicine. 2019 Mar 12;8:6-7. doi: 10.1016/j.eclinm.2019.03.004. eCollection 2019 Feb. No abstract available.

6.

A critical review on use of Agrobacterium rhizogenes and their associated binary vectors for plant transformation.

Bahramnejad B, Naji M, Bose R, Jha S.

Biotechnol Adv. 2019 Jun 8. pii: S0734-9750(19)30095-3. doi: 10.1016/j.biotechadv.2019.06.004. [Epub ahead of print] Review.

PMID:
31185263
7.

Enhancement of ABA sensitivity through conditional expression of ARF10 gene in Brassica juncea exhibit fertile plants with tolerance against Alternaria brassicicola.

Mukherjee A, Mazumder M, Jana J, Srivasatava AK, Mondal B, De A, Ghosh S, Saha U, Bose R, Chatterjee S, Dey N, Basu D.

Mol Plant Microbe Interact. 2019 Jun 11. doi: 10.1094/MPMI-05-19-0132-R. [Epub ahead of print]

PMID:
31184524
8.

Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.

Madheswaran T, Kandasamy M, Bose RJ, Karuppagounder V.

Drug Discov Today. 2019 Jul;24(7):1405-1412. doi: 10.1016/j.drudis.2019.05.004. Epub 2019 May 15. Review.

PMID:
31102731
9.

Molecular Imaging of Retinoic Acids in Live Cells Using Single-Chain Bioluminescence Probes.

Kim SB, Fujii R, Nishihara R, Bose RJ, Citterio D, Suzuki K, Massoud TF, Paulmurugan R.

ACS Comb Sci. 2019 Jun 10;21(6):473-481. doi: 10.1021/acscombsci.9b00035. Epub 2019 May 6.

PMID:
31034200
10.

Synthesis of Zwitterionic Copolymers via Copper-Mediated Aqueous Living Radical Grafting Polymerization on Starch.

Fan Y, Migliore N, Raffa P, Bose RK, Picchioni F.

Polymers (Basel). 2019 Jan 22;11(2). pii: E192. doi: 10.3390/polym11020192.

11.

Mine sludge waste recycling as bio-stimulant for applications in anaerobic wastewater treatment.

Bose RS, Tiwari MK.

Water Sci Technol. 2019 Feb;79(3):425-434. doi: 10.2166/wst.2019.058.

PMID:
30924797
12.

Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.

Ghosh N, Sanikommu S, Robinson M, Trivedi J, Brown T, Bose R, Park SI, Avalos BR, Copelan EA, Jacobs R, Hu B.

Br J Haematol. 2019 Aug;186(4):e65-e67. doi: 10.1111/bjh.15897. Epub 2019 Mar 28. No abstract available.

PMID:
30924125
13.

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

Meric-Bernstam F, Hurwitz H, Raghav KPS, McWilliams RR, Fakih M, VanderWalde A, Swanton C, Kurzrock R, Burris H, Sweeney C, Bose R, Spigel DR, Beattie MS, Blotner S, Stone A, Schulze K, Cuchelkar V, Hainsworth J.

Lancet Oncol. 2019 Apr;20(4):518-530. doi: 10.1016/S1470-2045(18)30904-5. Epub 2019 Mar 8.

PMID:
30857956
14.

Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer.

Xi J, Oza A, Thomas S, Ademuyiwa F, Weilbaecher K, Suresh R, Bose R, Cherian M, Hernandez-Aya L, Frith A, Peterson L, Luo J, Krishnamurthy J, Ma CX.

J Natl Compr Canc Netw. 2019 Feb;17(2):141-147. doi: 10.6004/jnccn.2018.7094.

PMID:
30787127
15.

Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.

Massicano AVF, Lee S, Crenshaw BK, Aweda TA, El Sayed R, Super I, Bose R, Marquez-Nostra BV, Lapi SE.

Cancer Biother Radiopharm. 2019 May;34(4):209-217. doi: 10.1089/cbr.2018.2654. Epub 2019 Jan 24.

PMID:
30676778
16.

Spinal cord stimulation for complex regional pain syndrome type I with spinal myoclonus - a case report and review of literature.

Bose R, Banerjee AD.

Br J Neurosurg. 2019 Jan 12:1-3. doi: 10.1080/02688697.2018.1552755. [Epub ahead of print]

PMID:
30636459
17.

Phrenic nerve stimulation for diaphragmatic pacing in chronic ventilator-dependent patients.

Bose R, Banerjee AD, Brajesh V, Narang KS, Dubey S, Singh VP.

Neurol India. 2018 Nov-Dec;66(6):1834-1837. doi: 10.4103/0028-3886.246256. No abstract available.

18.

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Nov 14;9(1):4850. doi: 10.1038/s41467-018-07407-3.

19.

Accomplishments and challenges in stem cell imaging in vivo.

Bose RJC, Mattrey RF.

Drug Discov Today. 2019 Feb;24(2):492-504. doi: 10.1016/j.drudis.2018.10.007. Epub 2018 Oct 17. Review.

PMID:
30342245
20.

Evaluation of the quality of transesophageal echocardiography images and verification of proficiency

Matyal R, Mahmood F, Knio ZO, Jones SB, Yeh L, Amir R, Bose R, Mitchell JD.

Echo Res Pract. 2018 Sep 1;5(3):89-95. doi: 10.1530/ERP-18-0002.

21.

Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia.

Bose RJ, Kim BJ, Arai Y, Han IB, Moon JJ, Paulmurugan R, Park H, Lee SH.

Biomaterials. 2018 Dec;185:360-370. doi: 10.1016/j.biomaterials.2018.08.018. Epub 2018 Aug 9.

PMID:
30273835
22.

Regulation of Transcription by Circular RNAs.

Bose R, Ain R.

Adv Exp Med Biol. 2018;1087:81-94. doi: 10.1007/978-981-13-1426-1_7. Review.

PMID:
30259359
23.

Spatio-temporal patterns of orchids flowering in Cameroonian rainforests.

Texier N, Deblauwe V, Stévart T, Sonké B, Simo-Droissart M, Azandi L, Bose R, Djuikouo MN, Kamdem G, Kamdem N, Mayogo S, Zemagho L, Droissart V.

Int J Biometeorol. 2018 Nov;62(11):1931-1944. doi: 10.1007/s00484-018-1594-3. Epub 2018 Sep 13.

PMID:
30215186
24.

The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Sep 4;9(1):3476. doi: 10.1038/s41467-018-05914-x. Erratum in: Nat Commun. 2018 Nov 14;9(1):4850.

25.

Reply to J.J. Tao et al.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Aug 10;36(23):2451. doi: 10.1200/JCO.2018.78.6392. Epub 2018 Jun 1. No abstract available.

PMID:
29856693
26.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.

Gullo G, Walsh N, Fennelly D, Bose R, Walshe J, Tryfonopoulos D, O'Mahony K, Hammond L, Silva N, McDonnell D, Ballot J, Quinn C, McDermott EW, Evoy D, Prichard R, Geraghty J, Amstrong J, Crown J.

Br J Cancer. 2018 Aug;119(3):374-380. doi: 10.1038/s41416-018-0114-x. Epub 2018 May 18.

27.

Evaluation of the quality of transesophageal echocardiography images and verification of proficiency.

Matyal R, Mahmood F, Knio ZO, Jones S, Yeh L, Amir R, Bose R, Mitchell JD.

Echo Res Pract. 2018 May 9. pii: ERP-18-0002. doi: 10.1530/ERP-18-0002. [Epub ahead of print]

28.

Biological Response to Time-Controlled Adaptive Ventilation Depends on Acute Respiratory Distress Syndrome Etiology.

Silva PL, Cruz FF, Samary CDS, Moraes L, de Magalhães RF, Fernandes MVS, Bose R, Pelegati VB, Carvalho HF, Capelozzi VL, Satalin J, Gatto L, Andrews P, Habashi N, Nieman G, Rocco PRM.

Crit Care Med. 2018 Jun;46(6):e609-e617. doi: 10.1097/CCM.0000000000003078.

PMID:
29485489
29.

Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.

Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA.

Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13.

30.

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.

Bose RJ, Paulmurugan R, Moon J, Lee SH, Park H.

Drug Discov Today. 2018 Apr;23(4):891-899. doi: 10.1016/j.drudis.2018.02.001. Epub 2018 Feb 6. Review.

PMID:
29426004
31.

Summative Objective Structured Clinical Examination Assessment at the End of Anesthesia Residency for Perioperative Ultrasound.

Mitchell JD, Amir R, Montealegre-Gallegos M, Mahmood F, Shnider M, Mashari A, Yeh L, Bose R, Wong V, Hess P, Amador Y, Jeganathan J, Jones SB, Matyal R.

Anesth Analg. 2018 Jun;126(6):2065-2068. doi: 10.1213/ANE.0000000000002826.

PMID:
29381519
32.

Decreased Clinical Severity of Strangles in Weanlings Associated with Restricted Seroconversion to Optimized Streptococcus equi ssp equi Assays.

Tscheschlok L, Venner M, Steward K, Böse R, Riihimäki M, Pringle J.

J Vet Intern Med. 2018 Jan;32(1):459-464. doi: 10.1111/jvim.15037.

33.

Phosphaplatin Anti-tumor Effect Enhanced by Liposomes Partly via an Up-regulation of PEDF in Breast Cancer.

Belkacemi L, Atkins JL, Yang LU, Gadgil P, Sater AK, Chow DS, Bose RN, Zhang SX.

Anticancer Res. 2018 Feb;38(2):623-646.

PMID:
29374685
34.

Simulation-based Assessment to Reliably Identify Key Resident Performance Attributes.

Blum RH, Muret-Wagstaff SL, Boulet JR, Cooper JB, Petrusa ER, Baker KH, Davidyuk G, Dearden JL, Feinstein DM, Jones SB, Kimball WR, Mitchell JD, Nadelberg RL, Wiser SH, Albrecht MA, Anastasi AK, Bose RR, Chang LY, Culley DJ, Fisher LJ, Grover M, Klainer SB, Kveraga R, Martel JP, McKenna SS, Minehart RD, Mitchell JD, Mountjoy JR, Pawlowski JB, Pilon RN, Shook DC, Silver DA, Warfield CA, Zaleski KL; Harvard Assessment of Anesthesia Resident Performance Research Group.

Anesthesiology. 2018 Apr;128(4):821-831. doi: 10.1097/ALN.0000000000002091.

PMID:
29369062
35.

Sox2 is required for olfactory pit formation and olfactory neurogenesis through BMP restriction and Hes5 upregulation.

Panaliappan TK, Wittmann W, Jidigam VK, Mercurio S, Bertolini JA, Sghari S, Bose R, Patthey C, Nicolis SK, Gunhaga L.

Development. 2018 Jan 19;145(2). pii: dev153791. doi: 10.1242/dev.153791.

36.

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Feb 20;36(6):536-542. doi: 10.1200/JCO.2017.75.3780. Epub 2018 Jan 10. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):360.

PMID:
29320312
37.

Molybdenum Sulphoselenophosphide Spheroids as an Effective Catalyst for Hydrogen Evolution Reaction.

Bose R, Jothi VR, Koh B, Jung C, Yi SC.

Small. 2018 Feb;14(8). doi: 10.1002/smll.201703862. Epub 2018 Jan 10.

PMID:
29318738
38.

Ubiquitin Ligase Huwe1 Modulates Spermatogenesis by Regulating Spermatogonial Differentiation and Entry into Meiosis.

Bose R, Sheng K, Moawad AR, Manku G, O'Flaherty C, Taketo T, Culty M, Fok KL, Wing SS.

Sci Rep. 2017 Dec 19;7(1):17759. doi: 10.1038/s41598-017-17902-0.

39.

Analyzing text recognition from tactually evoked EEG.

Khasnobish A, Datta S, Bose R, Tibarewala DN, Konar A.

Cogn Neurodyn. 2017 Dec;11(6):501-513. doi: 10.1007/s11571-017-9452-2. Epub 2017 Sep 6.

40.

Survival trends in glioma: Experience at a tertiary care centre.

Bose R, Narang KS, Bhangale D, Kedia R, Sharma V, Jha AN.

Neurol India. 2017 Nov-Dec;65(6):1295-1301. doi: 10.4103/0028-3886.217968.

PMID:
29133704
41.

Huwe1 Regulates the Establishment and Maintenance of Spermatogonia by Suppressing DNA Damage Response.

Fok KL, Bose R, Sheng K, Chang CW, Katz-Egorov M, Culty M, Su S, Yang M, Ruan YC, Chan HC, Iavarone A, Lasorella A, Cencic R, Pelletier J, Nagano M, Xu W, Wing SS.

Endocrinology. 2017 Nov 1;158(11):4000-4016. doi: 10.1210/en.2017-00396.

PMID:
28938460
42.

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types.

Kumar RD, Bose R.

Sci Rep. 2017 Jul 25;7(1):6418. doi: 10.1038/s41598-017-06366-x.

43.

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Ma CX, Bose R, Gao F, Freedman RA, Telli ML, Kimmick G, Winer E, Naughton M, Goetz MP, Russell C, Tripathy D, Cobleigh M, Forero A, Pluard TJ, Anders C, Niravath PA, Thomas S, Anderson J, Bumb C, Banks KC, Lanman RB, Bryce R, Lalani AS, Pfeifer J, Hayes DF, Pegram M, Blackwell K, Bedard PL, Al-Kateb H, Ellis MJC.

Clin Cancer Res. 2017 Oct 1;23(19):5687-5695. doi: 10.1158/1078-0432.CCR-17-0900. Epub 2017 Jul 5.

44.

ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.

Bose R, Karthaus WR, Armenia J, Abida W, Iaquinta PJ, Zhang Z, Wongvipat J, Wasmuth EV, Shah N, Sullivan PS, Doran MG, Wang P, Patruno A, Zhao Y; International SU2C/PCF Prostate Cancer Dream Team, Zheng D, Schultz N, Sawyers CL.

Nature. 2017 Jun 29;546(7660):671-675. doi: 10.1038/nature22820. Epub 2017 Jun 14.

45.

Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.

Bose RJC, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S, Thandavarayan RA.

Drug Discov Today. 2017 Aug;22(8):1258-1265. doi: 10.1016/j.drudis.2017.05.015. Epub 2017 Jun 8. Review.

PMID:
28600191
46.

Co-catalytic Effects of CoS2 on the Activity of the MoS2 Catalyst for Electrochemical Hydrogen Evolution.

Bose R, Jin Z, Shin S, Kim S, Lee S, Min YS.

Langmuir. 2017 Jun 13;33(23):5628-5635. doi: 10.1021/acs.langmuir.7b00580. Epub 2017 Jun 2.

PMID:
28544849
47.
48.

Valsalva maneuver aided adherent ventriculoperitoneal shunt removal.

Haldar R, Bose R, Samanta S, Das KK.

Asian J Neurosurg. 2017 Apr-Jun;12(2):339-340. doi: 10.4103/1793-5482.145536. No abstract available.

49.

Ultrasound as a Screening Tool for Central Venous Catheter Positioning and Exclusion of Pneumothorax.

Amir R, Knio ZO, Mahmood F, Oren-Grinberg A, Leibowitz A, Bose R, Shaefi S, Mitchell JD, Ahmed M, Bardia A, Talmor D, Matyal R.

Crit Care Med. 2017 Jul;45(7):1192-1198. doi: 10.1097/CCM.0000000000002451.

PMID:
28422778
50.

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.

Griffith M, Spies NC, Krysiak K, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, Jones MR, Bilski RL, Lesurf R, Feng YY, Shah NM, Bonakdar M, Trani L, Matlock M, Ramu A, Campbell KM, Spies GC, Graubert AP, Gangavarapu K, Eldred JM, Larson DE, Walker JR, Good BM, Wu C, Su AI, Dienstmann R, Margolin AA, Tamborero D, Lopez-Bigas N, Jones SJ, Bose R, Spencer DH, Wartman LD, Wilson RK, Mardis ER, Griffith OL.

Nat Genet. 2017 Jan 31;49(2):170-174. doi: 10.1038/ng.3774. No abstract available.

Supplemental Content

Support Center